The EVEREST project is all about expanding EV research and will focus on four key areas: standardized characterization and isolation of EVs; investigating EVs in Health or Disease and Enhancing Translational Biomarker Discovery; advancing EV-based therapeutics or drug delivery; and commercial development of EV-based technologies.

Within the framework of EVEREST, AcouSort will welcome external researchers from a variety of institutions around Europe to learn from their expertise and to educate them on the unique possibilities of acoustofluidics to significantly enhance speed and accuracy in an EV research setting.

As part of the project, AcouSort will also place some of its staff members on shorter secondments at institutions. During the secondments, they will be working with the AcouTrap to isolate novel sample types and to evaluate the output samples with new technologies, generation additional validation data for the AcouTrap system.

”The EVEREST project provides AcouSort with a truly fantastic opportunity to spread key knowledge and knowhow about our products and technology. The project will produce important data on the AcouTrap System which will be extremely beneficial in our efforts to establish this product as a state-of-the-art system for EV sample preparations,” says Agnes Michanek, Commercial Director at AcouSort.